Quantcast

Latest Clinical research Stories

2014-07-23 08:31:10

ENGLEWOOD, Colo., July 23 2014 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced the opening of its new headquarters, manufacturing and research facility: Ampio Pharmaceuticals,373 Inverness ParkwayEnglewood, CO 80112Direct: (720) 437-6500 Michael Macaluso, Ampio's CEO, noted "This advanced, labor efficient, pharmaceutical drug manufacturing facility will be fully operational this summer, right on schedule, to produce the first batches of Ampion(TM)...

2014-07-23 08:30:59

MARIETTA, Ga., July 23, 2014 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, processor and marketer of patent-protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today it has filed its initial Investigational New Drug ("IND") application with the Food and Drug Administration ("FDA"). The IND submission, which was filed yesterday, July 22, 2014, is the Company's initial submission for certain indications...

2014-07-22 12:30:23

Funding Opportunity to Facilitate Events that Advance Patient-Centered Outcomes Research WASHINGTON, July 22, 2014 /PRNewswire-USNewswire/ -- The Patient-Centered Outcomes Research Institute (PCORI) today launched a new funding opportunity through the Eugene Washington PCORI Engagement Awards program to support research meetings and events that will expand patient-centered outcomes research (PCOR) and patient-centered comparative clinical effectiveness research (CER). Eligible organizations...

2014-07-22 12:25:40

Cortellis solution becomes Pharma's most comprehensive source for data on clinical trials in less than a year PHILADELPHIA, July 22, 2014 /PRNewswire/ -- The Intellectual Property and Science business of Thomson Reuters, the world's leading provider of intelligent information for businesses and professionals, today announced Cortellis Clinical Trials Intelligence, its global clinical-drug-trial intelligence database, marked an industry-first milestone with the documentation of more...

2014-07-22 08:32:36

Additional Independent Review Board Approvals Expected for Phase 2 Trial (Study 202) SAN DIEGO, July 22, 2014 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that it has resumed enrollment and dosing of patients in its ongoing Phase 2 trial (Study 202) evaluating PEGPH20 in patients with pancreatic cancer under the revised clinical protocol agreed to with the FDA in June. PEGPH20 is an investigational PEGylated form of Halozyme's proprietary recombinant...

2014-07-21 23:06:38

GIA initiates research coverage on the global “Pediatric Drugs and Vaccines” market, as part of its ongoing multiple research projects on diverse industries and markets. The soon to be released report identifies rising incidence of metabolic conditions, cardiovascular and CNS diseases among children, rising per capita healthcare spends in emerging markets and a strong drug development pipeline, as primary growth drivers in the market. San Jose, California (PRWEB) July 21, 2014 Follow...

2014-07-21 12:25:35

SAN ANTONIO, July 21, 2014 /PRNewswire-USNewswire/ -- ADB International Group Inc.: OTCQB: ADBI (ADBI or the Company) today announced a partnership with Austen BioInnovation Institute in Akron (ABIA or the Institute), for the purpose of bringing ADBI's E-QURE BST(TM), a bioelectrical signal therapy device (the E-QURE BST Device), to the U.S. market. The Institute, which has significant expertise in wound healing, clinical trial development and regulatory operations, will conduct a...

2014-07-21 12:25:16

ALBANY, New York, July 21, 2014 /PRNewswire/ -- According to a new market report published by Transparency Market Research "E-Clinical Solution Software Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020," the global microfluidic device market was valued at USD 3,005 million in 2014 and is expected to grow at a CAGR of 13.8% from 2014 to 2020, to reach an estimated value of USD 6,515.3 million in 2020. Browse the full E-Clinical...

2014-07-21 10:19:04

North Shore-Long Island Jewish (LIJ) Health System The brain network measures placebo effects in Parkinson's disease patients Investigators at The Feinstein Institute for Medical Research have utilized a new image-based strategy to identify and measure placebo effects in randomized clinical trials for brain disorders. The findings are published in the August issue of The Journal of Clinical Investigation. Parkinson's disease is the second most common neurodegenerative disease in the...

2014-07-21 08:27:28

LONDON, July 21, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: The World Market for Biosimlars (EPO, G-CSF, HGH, Insulin, Interferon Alpha, Monoclonal Antibodies, Other), 4th Editionhttps://www.reportbuyer.com/product/2076279/The-World-Market-for-Biosimlars-EPO-G-CSF-HGH-Insulin-Interferon-Alpha-Monoclonal-Antibodies-Other-4th-Edition.html This study, The World Market for Biosimilars, 4th Edition (EPO, G-CSF, HGH, Insulin, Interferon alpha, mAbs,...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related